This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Cerubidine (Daunorubicin) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.
Reports by Event Outcome
All Cases (56)
Death (10)
Life Threatening Events (22)
Disability (4)
Reports by Reaction Type
Septic Shock (11),
Sepsis (10),
Pyrexia (9),
Acute Respiratory Distress Syndrome (9),
Aplasia (8),
Pleural Effusion (7),
Febrile Bone Marrow Aplasia (7),
Generalised Oedema (6),
Bone Marrow Failure (6),
Cytolytic Hepatitis (6),
Renal Failure (6),
Cholestasis (5)
Below are a few examples of reports where side effects / adverse reactions may be related to Cerubidine (Daunorubicin). For a complete list or a specific selection of reports, please use the links above.
Possible Cerubidine side effects in 44 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-08
Patient: 44 year old female
Reactions: Gastrointestinal Haemorrhage, Haemorrhage, Lung Disorder, Mesenteric Panniculitis, Sepsis, Febrile Bone Marrow Aplasia, Bone Marrow Failure, Infection
Drug(s) suspected as cause:
Cerubidine
Possible Cerubidine side effects in 44 year old female
Reported by a physician from France on 2012-07-27
Patient: 44 year old female
Reactions: Lung Disorder, Gastrointestinal Haemorrhage, Mesenteric Panniculitis, Sepsis, Febrile Bone Marrow Aplasia
Drug(s) suspected as cause:
Mylotarg
Dosage: 10.4 mg, 1x/day
Indication: Acute Leukaemia
Start date: 2008-07-25
End date: 2008-07-25
Cytarabine
Dosage: 348 mg, 1x/day
Indication: Acute Leukaemia
Start date: 2008-07-22
End date: 2008-07-28
Cerubidine
Dosage: 104.4 mg, 1x/day
Indication: Acute Leukaemia
Start date: 2008-07-22
End date: 2008-07-24
Possible Cerubidine side effects in 44 year old female
Reported by a physician from France on 2012-07-13
Patient: 44 year old female
Reactions: Gastrointestinal Haemorrhage, Lung Disorder, Mesenteric Panniculitis, Sepsis, Febrile Bone Marrow Aplasia
Drug(s) suspected as cause:
Cerubidine
Dosage: 104.4 mg, 1x/day
Indication: Acute Leukaemia
Start date: 2008-07-22
End date: 2008-07-24
Mylotarg
Dosage: 10.4 mg, 1x/day
Indication: Acute Leukaemia
Start date: 2008-07-25
End date: 2008-07-25
Cytarabine
Dosage: 348 mg, 1x/day
Indication: Acute Leukaemia
Start date: 2008-07-22
End date: 2008-07-28
Possible Cerubidine side effects in male
Reported by a physician from France on 2012-07-12
Patient: male, weighing 61.5 kg (135.3 pounds)
Reactions: Haemorrhagic Stroke, Thrombocytopenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Cytarabine
Dosage: 3650 mg, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-22
End date: 2012-06-11
Cerubidine
Dosage: 110 mg, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-22
End date: 2012-06-09
Afinitor
Dosage: 70 mg, unk
Administration route: Oral
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-22
End date: 2012-05-28
Other drugs received by patient: Ondansetron; Emend; Glucose
Possible Cerubidine side effects in male
Reported by a physician from France on 2012-07-02
Patient: male, weighing 61.5 kg (135.3 pounds)
Reactions: Haemorrhagic Stroke, Thrombocytopenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Cerubidine
Dosage: 110 mg, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-22
End date: 2012-06-09
Cytarabine
Dosage: 3650 mg, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-22
End date: 2012-06-11
Afinitor
Dosage: 70 mg, unk
Administration route: Oral
Start date: 2012-05-22
End date: 2012-05-28
Other drugs received by patient: Ondansetron; Emend; Glucose
Possible Cerubidine side effects in 55 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-06-04
Patient: 55 year old male
Reactions: Transfusion-Related Acute Lung Injury, Interstitial Lung Disease, Pleural Effusion
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 500 mg/m2 (1 g), 1x/day
Indication: Acute Myelomonocytic Leukaemia
Start date: 2012-02-23
End date: 2012-02-25
Neupogen
Dosage: 5 ug/kg (450 ug), 1x/day
Indication: Acute Myelomonocytic Leukaemia
Start date: 2012-02-23
End date: 2012-03-01
Perikabiven 1200
Dosage: unk
Indication: Parenteral Nutrition
Start date: 2012-02-29
End date: 2012-03-01
Cerubidine
Dosage: 60 mg/m2 (120 mg), 1x/day
Indication: Acute Myelomonocytic Leukaemia
Start date: 2012-02-23
End date: 2012-02-25
Other drugs received by patient: Lasix; Primperan TAB; Gaviscon; Zofran; Tiorfan; Tramadol; Paracetamol; Periferalgan; Ceftriaxone; Aciclovir; Hydrea; Folic Acid
Possible Cerubidine side effects in 55 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-06-04
Patient: 55 year old male
Reactions: Hyperbilirubinaemia, Cholestasis
Drug(s) suspected as cause:
Neupogen
Dosage: 450 /mm3, 1x/day (5 ug/kg/day)
Indication: Acute Myelomonocytic Leukaemia
Start date: 2012-02-23
End date: 2012-03-01
Cytarabine
Dosage: 1 g, 1x/day (500 mg/m2)
Indication: Acute Myelomonocytic Leukaemia
Start date: 2012-02-23
End date: 2012-02-25
Cerubidine
Dosage: 120 mg, 1x/day (60 mg/m2)
Indication: Acute Myelomonocytic Leukaemia
Start date: 2012-02-23
End date: 2012-02-25
Primperan TAB
Dosage: 2 to 5 vials
Indication: Vomiting
Start date: 2012-02-24
Other drugs received by patient: Folic Acid; Zofran; Lasix; Hydrea; Paracetamol
Possible Cerubidine side effects in 21 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-05-30
Patient: 21 year old male, weighing 82.6 kg (181.7 pounds)
Reactions: Toxic Optic Neuropathy
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Dexamethasone
Dosage: unk
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-10-20
End date: 2011-11-27
Valacyclovir Hydrochloride
Dosage: 1 g, 1x/day
Administration route: Oral
Start date: 2011-10-13
End date: 2011-12-07
Cerubidine
Dosage: 60 mg, cyclic
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-10-20
End date: 2011-11-10
Vfend
Dosage: unk
Start date: 2011-10-17
End date: 2011-12-07
Phenoxymethyl Penicillin
Dosage: 3 millioniu, 1x/day
Administration route: Oral
Start date: 2011-11-18
End date: 2011-12-07
Vincristine
Dosage: 2 mg, cyclic
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-10-20
End date: 2011-11-10
Nexium
Dosage: unk
Administration route: Oral
Start date: 2011-10-17
End date: 2011-11-11
Nexium
Dosage: unk
Administration route: Oral
Start date: 2011-11-15
End date: 2011-12-07
Kidrolase
Dosage: unk, cyclic
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-10-24
End date: 2011-11-16
Other drugs received by patient: Methotrexate; Cyclophosphamide; Cytarabine
Possible Cerubidine side effects in 13 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-05-29
Patient: 13 year old male
Reactions: Fungal Infection, Bacterial Infection, Aplasia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cerubidine
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-09-16
End date: 2011-09-30
Methotrexate
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-09-09
End date: 2011-10-03
Kidrolase
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-09-20
End date: 2011-10-03
Hydrocortisone ^upjohn^
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-09-20
End date: 2011-10-03
Cytarabine
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-09-20
End date: 2011-10-03
Vincristine
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-09-16
End date: 2011-09-30
Other drugs received by patient: Bactrim DS; Amikacin; Fasturtec; Prednisolone; Tazobactam
Possible Cerubidine side effects in male
Reported by a physician from France on 2012-05-25
Patient: male
Reactions: Toxic Optic Neuropathy
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Vincristine
Dosage: 2mg cyclic
Indication: T-Cell Type Acute Leukaemia
Start date: 2011-10-20
End date: 2011-11-10
Phenoxymethyl Penicillin
Dosage: 3iu6 per day
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-11-18
End date: 2011-12-07
Nexium
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-10-17
End date: 2011-12-07
Vfend
Indication: Product Used FOR Unknown Indication
Start date: 2011-10-17
End date: 2011-12-07
Dexamethasone
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-10-20
End date: 2011-10-27
Valacyclovir Hydrochloride
Dosage: 1g per day
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-10-13
End date: 2011-12-07
Kidrolase
Dosage: 10iu3 cyclic
Indication: T-Cell Type Acute Leukaemia
Start date: 2011-10-24
End date: 2011-11-16
Cerubidine
Dosage: 60mg cyclic
Indication: T-Cell Type Acute Leukaemia
Start date: 2011-10-20
End date: 2011-11-10
Other drugs received by patient: Methotrexate; Cyclophosphamide; Cytarabine
Possible Cerubidine side effects in 21 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-05-24
Patient: 21 year old male, weighing 82.6 kg (181.7 pounds)
Reactions: Toxic Optic Neuropathy
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Vfend
Dosage: unk
Start date: 2011-10-17
End date: 2011-12-07
Nexium
Dosage: unk
Administration route: Oral
Start date: 2011-11-15
End date: 2011-12-07
Valacyclovir Hydrochloride
Dosage: 1 g, 1x/day
Administration route: Oral
Start date: 2011-10-13
End date: 2011-12-07
Dexamethasone
Dosage: unk
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-10-20
End date: 2011-11-27
Cerubidine
Dosage: 60 mg, cyclic
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-10-20
End date: 2011-11-10
Phenoxymethyl Penicillin
Dosage: 3 millioniu, 1x/day
Administration route: Oral
Start date: 2011-11-18
End date: 2011-12-07
Vincristine
Dosage: 2 mg, cyclic
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-10-20
End date: 2011-11-10
Nexium
Dosage: unk
Administration route: Oral
Start date: 2011-10-17
End date: 2011-11-11
Kidrolase
Dosage: unk, cyclic
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-10-24
End date: 2011-11-16
Other drugs received by patient: Cyclophosphamide; Cytarabine; Methotrexate
Possible Cerubidine side effects in 13 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-05-23
Patient: 13 year old male
Reactions: Klebsiella Infection, Abdominal Pain, Diarrhoea, Fungal Infection, Blood Culture Positive, Bacterial Infection, Aplasia, Candidiasis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Methotrexate
Dosage: intradiscal (intraspinal)
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-09-09
End date: 2011-10-03
Hydrocortisone
Dosage: intradiscal (intraspinal)
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-09-20
End date: 2011-10-03
Cerubidine
Dosage: intravenous (not otherwise specified)
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-09-16
End date: 2011-09-30
Vincristine Sulfate
Dosage: in accordance with the cycle,intravenous (not otherwise specified)
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-09-16
End date: 2011-09-30
Cytarabine
Dosage: intradiscal (intraspinal)
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-09-20
End date: 2011-10-03
(Kidrolase)
Dosage: intravenous (not otherwise specified)
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-09-20
End date: 2011-10-03
Other drugs received by patient: Bactrim; (Amiklin / 00391001 / ); Tazobactam; Solupred / 00016217 / ); Fasturtec
Possible Cerubidine side effects in male
Reported by a physician from France on 2012-05-23
Patient: male
Reactions: Toxic Optic Neuropathy
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Vincristine
Dosage: 2 mg per course
Start date: 2011-10-27
Cerubidine
Dosage: 60 mg per course
Start date: 2011-10-20
Kidrolase
Start date: 2011-10-24
Vfend
Start date: 2011-10-17
End date: 2011-11-27
Valacyclovir Hydrochloride
Administration route: Oral
Start date: 2011-10-13
End date: 2011-12-07
Vincristine
Dosage: 2 mg per course
Start date: 2011-11-10
Cerubidine
Dosage: 60 mg per course
Start date: 2011-11-10
Vfend
Start date: 2011-11-28
End date: 2011-12-05
Dexamethasone
Dosage: daily
Administration route: Oral
Start date: 2011-10-20
End date: 2011-11-27
Phenoxymethyl Penicillin
Dosage: 3 000 000 iu
Administration route: Oral
Start date: 2011-11-18
End date: 2011-12-07
Kidrolase
Start date: 2011-10-27
Kidrolase
Start date: 2011-11-16
Cerubidine
Dosage: 60 mg per course
Start date: 2011-11-03
Nexium
Dosage: daily
Administration route: Oral
Start date: 2011-10-17
End date: 2011-11-11
Vincristine
Dosage: 2 mg per course
Start date: 2011-11-03
Kidrolase
Start date: 2011-11-10
Kidrolase
Start date: 2011-11-13
Kidrolase
Start date: 2011-11-06
Nexium
Administration route: Oral
Start date: 2011-11-15
End date: 2011-12-07
Vfend
Start date: 2011-12-06
End date: 2011-12-07
Vincristine
Dosage: 2 mg per course
Start date: 2011-10-20
Kidrolase
Start date: 2011-10-30
Kidrolase
Start date: 2011-11-03
Cerubidine
Dosage: 60 mg per course
Start date: 2011-10-27
Possible Cerubidine side effects in 55 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-05-22
Patient: 55 year old male
Reactions: Abdominal Pain, Hyperbilirubinaemia, Cholestasis, Pyrexia, Aplasia, Lung Disorder, Diarrhoea, Pleural Effusion, Acute Respiratory Distress Syndrome
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neupogen
Dosage: 450 mug, unk
Indication: Acute Myelomonocytic Leukaemia
Start date: 2012-02-23
End date: 2012-03-02
Primperan TAB
Dosage: unk
Indication: Vomiting
Start date: 2012-02-24
End date: 2012-03-01
Cytarabine
Dosage: 1 g, qd
Indication: Acute Myelomonocytic Leukaemia
Start date: 2012-02-23
End date: 2012-02-25
Cerubidine
Dosage: 120 mg, unk
Indication: Acute Myelomonocytic Leukaemia
Start date: 2012-02-23
End date: 2012-02-25
Other drugs received by patient: Gaviscon; Acetaminophen; Perikabiven; Ondansetron; Tramadol Hydrochloride; Hydrea; Kabiven; Vancomycin; Folic Acid; Lasix; Ceftriaxone Sodium; Acyclovir; Rovamycine / 00074401 /; Piperacilline Panpharma; Acetaminophen; Tiorfan
Possible Cerubidine side effects in 55 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-05-18
Patient: 55 year old male
Reactions: Abdominal Pain, Hyperbilirubinaemia, Cholestasis, Pyrexia, Aplasia, Lung Disorder, Diarrhoea, Pleural Effusion, Acute Respiratory Distress Syndrome
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cerubidine
Dosage: 120 mg, unk
Indication: Acute Myelomonocytic Leukaemia
Start date: 2012-02-23
End date: 2012-02-25
Primperan TAB
Dosage: unk
Indication: Vomiting
Start date: 2012-02-24
End date: 2012-03-01
Cytarabine
Dosage: 1 g, qd
Indication: Acute Myelomonocytic Leukaemia
Start date: 2012-02-23
End date: 2012-02-25
Neupogen
Dosage: 450 mug, unk
Indication: Acute Myelomonocytic Leukaemia
Start date: 2012-02-23
End date: 2012-03-02
Other drugs received by patient: Vancomycin; Acyclovir; Rovamycine / 00074401 /; Hydrea; Perikabiven; Ceftriaxone Sodium; Tiorfan; Kabiven; Folic Acid; Lasix; Ondansetron; Acetaminophen; Gaviscon; Acetaminophen; Piperacilline Panpharma; Tramadol Hydrochloride
Possible Cerubidine side effects in 68 year old male
Reported by a physician from Switzerland on 2012-04-24
Patient: 68 year old male
Reactions: Bronchopulmonary Aspergillosis, Blood Bilirubin Increased, Alanine Aminotransferase Increased, Cholestasis, Cardiac Disorder, Hepatic Steatosis, Multi-Organ Failure, Hepatic Encephalopathy, Lower Gastrointestinal Haemorrhage, Upper Gastrointestinal Haemorrhage, Renal Failure Acute
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Tazobactam
Dosage: unk
Indication: Aspergilloma
Start date: 2005-02-12
End date: 2005-03-04
Cerubidine
Dosage: unknown
Indication: Acute Lymphocytic Leukaemia
Start date: 2005-02-09
End date: 2005-03-07
Methotrexate Sodium
Dosage: unknown
Indication: Acute Lymphocytic Leukaemia
Start date: 2005-02-09
End date: 2005-03-07
Oncovin
Dosage: unknown
Indication: Acute Lymphocytic Leukaemia
Start date: 2005-02-09
End date: 2005-03-07
Cyclophosphamide
Dosage: unknown
Indication: Acute Lymphocytic Leukaemia
Start date: 2005-02-09
End date: 2005-03-07
Valtrex
Dosage: unknown
Indication: Aspergilloma
Start date: 2005-02-20
End date: 2005-03-08
Asparaginase
Dosage: unknown
Indication: Acute Lymphocytic Leukaemia
Start date: 2005-02-09
End date: 2005-03-07
Fungizone
Dosage: unknown
Indication: Aspergilloma
Start date: 2005-02-01
End date: 2005-02-01
Vfend
Dosage: unk
Indication: Aspergilloma
Start date: 2005-02-20
End date: 2005-03-08
Other drugs received by patient: Bactrim; Prednisone; Navoban; Torsemide
Possible Cerubidine side effects in 36 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-04-10
Patient: 36 year old male
Reactions: Palmar-Plantar Erythrodysaesthesia Syndrome, Coma, Pyrexia, Hallucination, Dermatitis Exfoliative
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-01-28
End date: 2012-02-04
Cytarabine
Dosage: 40 mg, unk
Start date: 2012-02-09
End date: 2012-02-09
Cytarabine
Dosage: 3220 mg, unk
Start date: 2012-02-10
End date: 2012-02-12
Cerubidine
Dosage: unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-01-30
End date: 2012-02-01
Cytarabine
Dosage: 40 mg, unk
Start date: 2012-02-07
End date: 2012-02-07
Cerubidine
Dosage: 58 mg, cyclic
Start date: 2012-02-10
End date: 2012-02-11
Other drugs received by patient: Vfend; Rocephin; Piperacillin and Tazobactam; Piperacillin and Tazobactam; Depo-Medrol; Methotrexate; Rocephin; Methotrexate; Fasturtec; Hydrea; Vancomycin; Rovamycine; Flagyl; Depo-Medrol; Ofloxacin; Vfend; Piperacillin and Tazobactam; Vancomycin
Possible Cerubidine side effects in 36 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-04-03
Patient: 36 year old male
Reactions: Palmar-Plantar Erythrodysaesthesia Syndrome, Coma, Pyrexia, Hallucination, Dermatitis Exfoliative
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 3220 mg, unk
Start date: 2012-02-10
End date: 2012-02-12
Cerubidine
Dosage: unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-01-30
End date: 2012-02-01
Cytarabine
Dosage: 40 mg, unk
Start date: 2012-02-09
End date: 2012-02-09
Cerubidine
Dosage: 58 mg, cyclic
Start date: 2012-02-10
End date: 2012-02-11
Cytarabine
Dosage: unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-01-28
End date: 2012-02-04
Cytarabine
Dosage: 40 mg, unk
Start date: 2012-02-07
End date: 2012-02-07
Other drugs received by patient: Rocephin; Ofloxacin; Flagyl; Piperacillin and Tazobactam; Piperacillin and Tazobactam; Fasturtec; Piperacillin and Tazobactam; Depo-Medrol; Methotrexate; Vfend; Vancomycin; Rocephin; Vancomycin; Depo-Medrol; Hydrea; Rovamycine; Vfend; Methotrexate
Possible Cerubidine side effects in 16 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-03-23
Patient: 16 year old female
Reactions: Mucosal Inflammation, Dermatitis Bullous
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 30 mg, single
Indication: T-Cell Type Acute Leukaemia
Start date: 2012-01-21
End date: 2012-01-21
Methotrexate
Dosage: 8220 mg, single
Start date: 2012-01-20
End date: 2012-01-20
Methotrexate
Dosage: 12 mg, single
Indication: T-Cell Type Acute Leukaemia
Start date: 2012-01-21
End date: 2012-01-21
Cerubidine
Dosage: 57 mg, 1x/day
Indication: T-Cell Type Acute Leukaemia
Start date: 2012-01-24
End date: 2012-01-24
Hydrocortisone
Dosage: 15 mg, single
Start date: 2012-01-26
End date: 2012-01-26
Mesna
Dosage: 330 mg, 1x/day
Indication: T-Cell Type Acute Leukaemia
Start date: 2012-01-20
End date: 2012-01-24
Cytarabine
Dosage: 30 mg, single
Start date: 2012-01-26
End date: 2012-01-26
Hydrocortisone
Dosage: 15 mg, single
Indication: T-Cell Type Acute Leukaemia
Start date: 2012-01-21
End date: 2012-01-21
Methotrexate
Dosage: 12 mg, 1x/day
Start date: 2012-01-26
End date: 2012-01-26
Ifosfamide
Dosage: 656 mg, 1x/day
Indication: T-Cell Type Acute Leukaemia
Start date: 2012-01-20
End date: 2012-01-24
Eldisine
Dosage: 4 mg, single
Start date: 2012-01-20
End date: 2012-01-20
Other drugs received by patient: Furosemide; Calcium Levofolinate
Possible Cerubidine side effects in 38 year old male
Reported by a physician from France on 2012-03-15
Patient: 38 year old male
Reactions: Acute Respiratory Distress Syndrome, Bone Marrow Failure, Septic Shock
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 380 mg, 1x/day
Indication: Acute Myeloid Leukaemia
Start date: 2011-04-05
End date: 2011-04-11
Cerubidine
Dosage: 114 mg, 1x/day
Indication: Acute Myeloid Leukaemia
Start date: 2011-04-05
End date: 2011-04-07
Possible Cerubidine side effects in 68 year old male
Reported by a physician from Switzerland on 2012-02-10
Patient: 68 year old male
Reactions: Bronchopulmonary Aspergillosis, Blood Bilirubin Increased, Alanine Aminotransferase Increased, Cholestasis, Cardiac Disorder, Hepatic Steatosis, Multi-Organ Failure, Hepatic Encephalopathy, Lower Gastrointestinal Haemorrhage, Upper Gastrointestinal Haemorrhage, Renal Failure Acute
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Valtrex
Dosage: unknown
Indication: Aspergilloma
Start date: 2005-02-20
End date: 2005-03-08
Oncovin
Dosage: unknown
Indication: Acute Lymphocytic Leukaemia
Start date: 2005-02-09
End date: 2005-03-07
Cerubidine
Dosage: unknown
Indication: Acute Lymphocytic Leukaemia
Start date: 2005-02-09
End date: 2005-03-07
Methotrexate Sodium
Dosage: unknown
Indication: Acute Lymphocytic Leukaemia
Start date: 2005-02-09
End date: 2005-03-07
Asparaginase
Dosage: unknown
Indication: Acute Lymphocytic Leukaemia
Start date: 2005-02-09
End date: 2005-03-07
Fungizone
Dosage: unknown
Indication: Aspergilloma
Start date: 2005-02-01
End date: 2005-02-01
Cyclophosphamide
Dosage: unknown
Indication: Acute Lymphocytic Leukaemia
Start date: 2005-02-09
End date: 2005-03-07
Tazobactam
Dosage: unk
Indication: Aspergilloma
Start date: 2005-02-12
End date: 2005-03-04
Vfend
Dosage: unk
Indication: Aspergilloma
Start date: 2005-02-20
End date: 2005-03-08
Other drugs received by patient: Prednisone; Torsemide; Bactrim; Navoban
Possible Cerubidine side effects in 51 year old female
Reported by a physician from France on 2012-01-20
Patient: 51 year old female
Reactions: Bone Marrow Failure
Drug(s) suspected as cause:
Cytarabine
Dosage: 320 mg, 1x/day
Indication: Acute Leukaemia
Start date: 2011-02-11
End date: 2011-02-17
Cerubidine
Dosage: 96 mg, 1x/day
Indication: Acute Leukaemia
Start date: 2011-02-11
End date: 2011-02-13
Possible Cerubidine side effects in 5 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-01-16
Patient: 5 year old male, weighing 18.0 kg (39.6 pounds)
Reactions: Sepsis, Generalised Oedema
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Gleevec
Administration route: Oral
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-13
End date: 2011-10-21
Cyclophosphamide
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-06
End date: 2011-10-01
Kidrolase
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-06
End date: 2011-10-14
Methotrexate
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-03
End date: 2011-10-14
Vincristine Sulfate
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-06
End date: 2011-10-13
Cerubidine
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-06
End date: 2011-10-13
Cytarabine
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-10
End date: 2011-10-14
Possible Cerubidine side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-01-09
Patient: male, weighing 18.0 kg (39.6 pounds)
Reactions: Urine Output Decreased, Pyrexia, Aplasia, Stomatococcal Infection, Pericardial Effusion, Generalised Oedema, Ascites, Staphylococcal Infection, Spleen Disorder, Oral Disorder, Sepsis, Hypoxia, Acute Respiratory Distress Syndrome, Pleural Effusion, Candidiasis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 25 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-10
End date: 2011-10-14
Gleevec
Dosage: 200 mg, qd
Administration route: Oral
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-13
End date: 2011-10-21
Cerubidine
Dosage: 31 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-06
End date: 2011-10-13
Methotrexate
Dosage: 12 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-03
End date: 2011-10-14
Vincristine
Dosage: 1.2 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-06
End date: 2011-10-13
Kidrolase
Dosage: 4800 iu, unk
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-06
End date: 2011-10-14
Cyclophosphamide
Dosage: 780 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-06
Possible Cerubidine side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-01-09
Patient: male, weighing 18.0 kg (39.6 pounds)
Reactions: Urine Output Decreased, Pyrexia, Stomatococcal Infection, Aplasia, Generalised Oedema, Ascites, Pericardial Effusion, Staphylococcal Infection, Oral Disorder, Sepsis, Hypoxia, Pleural Effusion, Acute Respiratory Distress Syndrome, Candidiasis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Gleevec
Dosage: 200 mg, qd
Administration route: Oral
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-13
End date: 2011-10-21
Cyclophosphamide
Dosage: 780 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-06
Cytarabine
Dosage: 25 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-10
End date: 2011-10-14
Methotrexate
Dosage: 12 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-03
End date: 2011-10-14
Vincristine
Dosage: 1.2 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-06
End date: 2011-10-13
Kidrolase
Dosage: 4800 iu, unk
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-06
End date: 2011-10-14
Cerubidine
Dosage: 31 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-06
End date: 2011-10-13
Possible Cerubidine side effects in 5 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-01-05
Patient: 5 year old male, weighing 18.0 kg (39.6 pounds)
Reactions: Sepsis, Generalised Oedema
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Gleevec
Administration route: Oral
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-13
End date: 2011-10-21
Cerubidine
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-06
End date: 2011-10-13
Methotrexate
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-03
End date: 2011-10-14
Cytarabine
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-10
End date: 2011-10-14
Kidrolase
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-06
End date: 2011-10-14
Cyclophosphamide
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-06
End date: 2011-10-01
Vincristine Sulfate
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-06
End date: 2011-10-13
Possible Cerubidine side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-01-02
Patient: male, weighing 18.0 kg (39.6 pounds)
Reactions: Urine Output Decreased, Pyrexia, Stomatococcal Infection, Aplasia, Ascites, Pericardial Effusion, Generalised Oedema, Staphylococcal Infection, Oral Disorder, Sepsis, Hypoxia, Pleural Effusion, Acute Respiratory Distress Syndrome, Candidiasis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Kidrolase
Dosage: 4800 iu, unk
Start date: 2011-10-06
End date: 2011-10-14
Cerubidine
Dosage: 31 mg, unk
Start date: 2011-10-06
End date: 2011-10-13
Cytarabine
Dosage: 25 mg, unk
Start date: 2011-10-10
End date: 2011-10-14
Cyclophosphamide
Dosage: 780 mg, unk
Start date: 2011-10-06
Vincristine Sulfate
Dosage: 1.2 mg, unk
Start date: 2011-10-06
End date: 2011-10-13
Gleevec
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2011-10-13
End date: 2011-10-21
Methotrexate
Dosage: 12 mg, unk
Start date: 2011-10-03
End date: 2011-10-14
Possible Cerubidine side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2011-12-31
Patient: male, weighing 18.0 kg (39.6 pounds)
Reactions: Urine Output Decreased, Pyrexia, Stomatococcal Infection, Aplasia, Pericardial Effusion, Generalised Oedema, Ascites, Staphylococcal Infection, Oral Disorder, Sepsis, Pleural Effusion, Hypoxia, Acute Respiratory Distress Syndrome, Candidiasis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Vincristine Sulfate
Dosage: 1.2 mg, unk
Start date: 2011-10-06
End date: 2011-10-13
Cytarabine
Dosage: 25 mg, unk
Start date: 2011-10-10
End date: 2011-10-14
Cerubidine
Dosage: 31 mg, unk
Start date: 2011-10-06
End date: 2011-10-13
Methotrexate
Dosage: 12 mg, unk
Start date: 2011-10-03
End date: 2011-10-14
Gleevec
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2011-10-13
End date: 2011-10-21
Cyclophosphamide
Dosage: 780 mg, unk
Start date: 2011-10-06
Kidrolase
Dosage: 4800 iu, unk
Start date: 2011-10-06
End date: 2011-10-14
Possible Cerubidine side effects in 61 year old female
Reported by a physician from France on 2011-12-27
Patient: 61 year old female, weighing 62.0 kg (136.4 pounds)
Reactions: Autoimmune Thrombocytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 340 mg/24h, unk
Start date: 2008-01-28
End date: 2008-02-03
Cordarone
Dosage: 200 mg/24h, unk
Administration route: Oral
Start date: 2008-01-19
End date: 2008-04-14
Cerubidine
Dosage: 105 mg/24h, unk
Start date: 2008-01-28
End date: 2008-01-30
Gemtuzumab Ozogamicin
Dosage: 5 mg/24h, unk
Start date: 2008-01-28
End date: 2008-02-03
Possible Cerubidine side effects in 61 year old female
Reported by a physician from France on 2011-12-21
Patient: 61 year old female, weighing 62.0 kg (136.4 pounds)
Reactions: Autoimmune Thrombocytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cerubidine
Dosage: 105 mg/24h, unk
Start date: 2008-01-28
End date: 2008-01-30
Gemtuzumab Ozogamicin
Dosage: 5 mg/24h, unk
Start date: 2008-01-28
End date: 2008-02-03
Cytarabine
Dosage: 340 mg/24h, unk
Start date: 2008-01-28
End date: 2008-02-03
Cordarone
Dosage: 200 mg/24h, unk
Administration route: Oral
Start date: 2008-01-19
End date: 2008-04-14
|